Asthika Goonewardene
Stock Analyst at Truist Securities
(2.15)
# 2,885
Out of 5,124 analysts
94
Total ratings
40.22%
Success rate
-3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Asthika Goonewardene
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZYME Zymeworks | Initiates: Buy | $40 | $24.18 | +65.43% | 1 | Dec 17, 2025 | |
| AVBP ArriVent BioPharma | Initiates: Buy | $43 | $18.93 | +127.15% | 1 | Nov 25, 2025 | |
| MRSN Mersana Therapeutics | Downgrades: Hold | $36 → $31 | $29.30 | +4.95% | 6 | Nov 13, 2025 | |
| GMAB Genmab | Reiterates: Buy | $49 → $48 | $33.10 | +45.02% | 16 | Nov 7, 2025 | |
| GILD Gilead Sciences | Reiterates: Buy | $127 → $145 | $121.36 | +19.48% | 3 | Nov 3, 2025 | |
| RCUS Arcus Biosciences | Reiterates: Buy | $32 → $39 | $21.69 | +79.81% | 2 | Oct 7, 2025 | |
| JANX Janux Therapeutics | Initiates: Buy | $100 | $13.44 | +644.05% | 1 | Sep 10, 2025 | |
| RVMD Revolution Medicines | Initiates: Buy | $99 | $79.85 | +23.98% | 1 | Sep 5, 2025 | |
| EXEL Exelixis | Maintains: Buy | $56 → $49 | $43.68 | +12.18% | 11 | Jul 29, 2025 | |
| BNTX BioNTech SE | Reiterates: Buy | $151 → $155 | $98.09 | +58.02% | 3 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $71 | $20.98 | +238.42% | 2 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $10 | $1.41 | +609.22% | 7 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $2.00 | +400.00% | 4 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $15 | $2.55 | +488.24% | 6 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $18.66 | +87.57% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $87 → $136 | $62.01 | +119.32% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $150 | $11.52 | +1,202.08% | 6 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.55 | +158.06% | 5 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 | $1.72 | +1,004.65% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $432 | $8.05 | +5,266.46% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Hold | $120 | $6.66 | +1,701.80% | 1 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $100 → $60 | $1.25 | +4,700.00% | 3 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $228 → $180 | $12.99 | +1,285.68% | 4 | Aug 23, 2022 |
Zymeworks
Dec 17, 2025
Initiates: Buy
Price Target: $40
Current: $24.18
Upside: +65.43%
ArriVent BioPharma
Nov 25, 2025
Initiates: Buy
Price Target: $43
Current: $18.93
Upside: +127.15%
Mersana Therapeutics
Nov 13, 2025
Downgrades: Hold
Price Target: $36 → $31
Current: $29.30
Upside: +4.95%
Genmab
Nov 7, 2025
Reiterates: Buy
Price Target: $49 → $48
Current: $33.10
Upside: +45.02%
Gilead Sciences
Nov 3, 2025
Reiterates: Buy
Price Target: $127 → $145
Current: $121.36
Upside: +19.48%
Arcus Biosciences
Oct 7, 2025
Reiterates: Buy
Price Target: $32 → $39
Current: $21.69
Upside: +79.81%
Janux Therapeutics
Sep 10, 2025
Initiates: Buy
Price Target: $100
Current: $13.44
Upside: +644.05%
Revolution Medicines
Sep 5, 2025
Initiates: Buy
Price Target: $99
Current: $79.85
Upside: +23.98%
Exelixis
Jul 29, 2025
Maintains: Buy
Price Target: $56 → $49
Current: $43.68
Upside: +12.18%
BioNTech SE
Jun 3, 2025
Reiterates: Buy
Price Target: $151 → $155
Current: $98.09
Upside: +58.02%
May 14, 2025
Maintains: Buy
Price Target: $88 → $71
Current: $20.98
Upside: +238.42%
May 14, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $1.41
Upside: +609.22%
Apr 1, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $2.00
Upside: +400.00%
Mar 3, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $2.55
Upside: +488.24%
Jan 8, 2025
Initiates: Buy
Price Target: $35
Current: $18.66
Upside: +87.57%
Nov 12, 2024
Maintains: Buy
Price Target: $87 → $136
Current: $62.01
Upside: +119.32%
Aug 16, 2024
Maintains: Buy
Price Target: $180 → $150
Current: $11.52
Upside: +1,202.08%
May 21, 2024
Maintains: Buy
Price Target: $5 → $4
Current: $1.55
Upside: +158.06%
May 16, 2024
Maintains: Buy
Price Target: $19
Current: $1.72
Upside: +1,004.65%
Sep 6, 2023
Reiterates: Buy
Price Target: $432
Current: $8.05
Upside: +5,266.46%
Apr 5, 2023
Reinstates: Hold
Price Target: $120
Current: $6.66
Upside: +1,701.80%
Aug 23, 2022
Maintains: Hold
Price Target: $100 → $60
Current: $1.25
Upside: +4,700.00%
Aug 23, 2022
Maintains: Buy
Price Target: $228 → $180
Current: $12.99
Upside: +1,285.68%